Page 1 of 1

Irish HSE to reconsider funding of MS drug Fampyra

Posted: Wed Nov 19, 2014 5:41 am
by MSUK
The Irish Health Service Executive has said its drugs committee will meet to reconsider a decision not to fund a life-changing drug for multiple sclerosis patients.

Fampyra, or Fampridine, which is made by Biogen Idec, costs between €220 and €500 for a monthly dose.

Patients were receiving the drug for free until July of this year, but since then they have had to start paying for it themselves..... Read More - http://www.ms-uk.org/ampyra